ESC Premium Access

The impact of highest doses of ACEi/ARB therapy on mortality of patients suffering from heart failure with reduced ejection fraction: a long-term follow-up, propensity-matched cohort study

Congress Session

About the speaker

Doctor Balazs Muk

Medical Centre, Hungarian Defence Forces, Budapest (Hungary)
1 presentation
0 follower

8 more presentations in this session

Pharmacological treatment of patients with HFrEF: is it really optimized in case of CRT and/or ICD implantation?

Speaker: Professor D. Logeart (Paris, FR)

Thumbnail

Evolution of level of evidence c recommendations in european society of cardiology clinical practice guidelines on heart failure

Speaker: Doctor M. Trindade (Lisbon, PT)

Thumbnail

Therapy treatment, adherence and persistence in chronic heart failure patients: a populaion study, from 2005 to TO 2012 in Lombardy

Speaker: Doctor S. Scalvini (Lumezzan, IT)

Thumbnail

The myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Speaker: Doctor N. Pavo (Vienna, AT)

Thumbnail

All cause mortality outcomes of various types of stem cell therapies in patients with dilated cardiomyopathy: an updated meta analysis and systematic review

Speaker: Doctor Y. Illahi (Multan, PK)

Thumbnail

Access the full session

Poster Session 2 - Treatment of heart failure

Speakers: Doctor B. Muk, Professor D. Logeart, Doctor M. Trindade, Doctor S. Scalvini, Doctor N. Pavo...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk